| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/04/2013 | US8454993 Controlled release pharmaceutical compositions of pregabalin |
| 06/04/2013 | US8454992 Paneled capsule shells for release of pharmaceutical compositions |
| 06/04/2013 | US8454991 Method and device for photodynamic therapy |
| 06/04/2013 | US8454989 Fluid dose on ingestion sheet; accuracte dosage |
| 06/04/2013 | US8454987 Biocompatible transparent sheet, method for producing the same, and cultured cell sheet used the same sheet |
| 06/04/2013 | US8454984 Antimicrobial resin compositions |
| 06/04/2013 | US8454980 Hydrogel bioscaffold and coating for bone and tooth repair |
| 06/04/2013 | US8454964 Three dimensionally crosslinked agarose bead with grass pollen covalently bound; immunotherapy, vaccines, diagnosis |
| 06/04/2013 | US8454951 Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women |
| 06/04/2013 | US8454939 Low dose pharmaceutical powders for inhalation |
| 06/04/2013 | US8454938 Treatment of respiratory diseases |
| 06/04/2013 | US8454937 Method and composition for the site-selective delivery using viruses encapsulated in microbubbles |
| 06/04/2013 | US8454582 Methods and devices for the treatment of ocular conditions |
| 06/04/2013 | US8454581 Infusion pump systems and methods |
| 06/04/2013 | CA2716449C Calcium carbonate granulation |
| 06/04/2013 | CA2637274C Soft-gelatin capsule formulation |
| 06/04/2013 | CA2618799C Aqueous anaesthetic compositions comprising propofol |
| 06/04/2013 | CA2610749C Pharmaceutical composition comprising 2,3-dihydro-6-nitroimidazo [2,1-b]oxazole derivatives |
| 06/04/2013 | CA2577862C Pharmaceutical composition comprising diclofenac |
| 06/04/2013 | CA2551022C Polyethyleneglycol-modified lipid compounds and uses thereof |
| 06/04/2013 | CA2539637C Coated tablets |
| 05/30/2013 | WO2013078422A2 Natural combination hormone replacement formulations and therapies |
| 05/30/2013 | WO2013078264A1 Pharmaceutical formulations |
| 05/30/2013 | WO2013077851A1 Immediate release abuse deterrent tablet |
| 05/30/2013 | WO2013077847A1 Oral dosage forms for delivering gabapentin |
| 05/30/2013 | WO2013077830A1 Synergistilly active combinations of roflumilast and carmoterol |
| 05/30/2013 | WO2013077829A1 Water-soluble pharmaceutical granules |
| 05/30/2013 | WO2013077825A1 Preparation process for a formulation comprising metformin |
| 05/30/2013 | WO2013077824A1 Preparation process for a formulation comprising metformin |
| 05/30/2013 | WO2013077823A1 Fast-dispersing nateglinide formulations |
| 05/30/2013 | WO2013077822A1 New formulations for treatment of diabetes |
| 05/30/2013 | WO2013077821A1 Homogeneous biguanide composition |
| 05/30/2013 | WO2013077820A1 Treatment package composed of dosage forms comprising nateglinide -metformin hydrochloride |
| 05/30/2013 | WO2013077819A1 Pharmaceutical formulations comprising nateglinide |
| 05/30/2013 | WO2013077815A1 Imatinib solid dosage forms reconstituted just before use |
| 05/30/2013 | WO2013077716A1 Method for obtaining water-insoluble and water-soluble essential oils from plant materials |
| 05/30/2013 | WO2013077681A1 Transdermal delivery system of bioactive molecules of skin using intracellular molecule delivery peptides |
| 05/30/2013 | WO2013077620A1 Water insoluble gel composition and method for preparing same |
| 05/30/2013 | WO2013077533A1 Chewable sildenafil citrate tablets in which bitterness is masked, and production method therefor |
| 05/30/2013 | WO2013076507A2 Platelet lysate gel |
| 05/30/2013 | WO2013076216A1 Controlled release particles comprising dimethyl fumarate |
| 05/30/2013 | WO2013076170A1 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid for the treatment of psoriasis |
| 05/30/2013 | WO2013076162A1 Formulations useful in the treatment of osteoarticular diseases |
| 05/30/2013 | WO2013076160A1 Sustained release formulations useful in the treatment of diseases |
| 05/30/2013 | WO2013076121A1 Pharmaceutical composition comprising myo-inositol and d-chiro-inositol |
| 05/30/2013 | WO2013075846A1 Pharmaceutical composition for treatment of allergic reactions |
| 05/30/2013 | WO2013075823A1 Transdermal therapeutic system comprising rotigotine and crystallization inhibitor |
| 05/30/2013 | WO2013075822A1 Transdermal therapeutic system (tts) with rotigotine |
| 05/30/2013 | WO2013075724A1 A method of producing a delivery device |
| 05/30/2013 | WO2013075394A1 Drug carrier with chelating composite micell and use thereof |
| 05/30/2013 | WO2013075186A1 Polymeric nanospheres coated with chitosan folate and use of the same |
| 05/30/2013 | WO2013050539A3 Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist |
| 05/30/2013 | WO2013049834A3 Electrokinetic pump based wound treatment system and methods |
| 05/30/2013 | WO2013023856A8 Use of a polysaccharide polymer from the seeds of the tamarind tree in protecting against tobacco-associated damages |
| 05/30/2013 | WO2013018050A3 Dissolution enhanced controlled drug delivery system for poorly water soluble drugs |
| 05/30/2013 | WO2013016006A8 Functionalized calcium phosphate artificial bone and joint compositions and methods of use and manufacture |
| 05/30/2013 | WO2009048698A4 Co-solvent compositions and methods for improved delivery of dantrolene therapeutic agents |
| 05/30/2013 | US20130138089 Two-piece, internal-channel osmotic delivery system flow modulator |
| 05/30/2013 | US20130138056 Nonaqueous pressure-sensitive adhesive for medicinal tape preparation for percutaneous absorption, medicinal tape preparation for percutaneous absorption, and process for producing the same |
| 05/30/2013 | US20130137976 Functional, Cross-Linked Nanostructures for Tandem Optical Imaging and Therapy |
| 05/30/2013 | US20130137917 Double emulsion core-shell nano-structure and preparation methods thereof |
| 05/30/2013 | US20130137835 Preparation of Polyphosphazene Microspheres |
| 05/30/2013 | US20130137782 Method of producing composition having continuous phase and disperse phase dispersed finely in the continuous phase and apparatus for producing the compositon |
| 05/30/2013 | US20130137769 Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts |
| 05/30/2013 | US20130137742 Ketorolac tromethamine compositions for treating or preventing ocular pain |
| 05/30/2013 | US20130137739 Solid dispersion comprising triazole compound |
| 05/30/2013 | US20130137698 Solid oral film dosage forms and methods for making same |
| 05/30/2013 | US20130137651 Gel useful for the delivery of ophthalmic drugs |
| 05/30/2013 | US20130137630 Formulations for infusion of type b lantibiotics |
| 05/30/2013 | US20130136805 Foamable compositions of stabilized chlorite |
| 05/30/2013 | US20130136798 Novel parenteral controlled release formulations of nsaid's |
| 05/30/2013 | US20130136797 Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes |
| 05/30/2013 | US20130136796 Acellular Bioabsorbable Tissue Regeneration Matrices |
| 05/30/2013 | US20130136793 High Content Sodium Ibuprofen Granules, Their Preparation and Their Use in Preparing Non-Effervescent Solid Dosage Forms |
| 05/30/2013 | US20130136792 Multi phase soft gel capsules, apparatus and method thereof |
| 05/30/2013 | US20130136791 Multi-phase, mult-compartment capsular delivery apparatus and methods for using same |
| 05/30/2013 | US20130136790 Liposomes with improved drug retention for treatment of cancer |
| 05/30/2013 | US20130136789 Agent for treating renal fibrosis |
| 05/30/2013 | US20130136787 Liposomal Camptothecins and Uses Thereof |
| 05/30/2013 | US20130136784 Methods for delivery of medication using dissolvable devices |
| 05/30/2013 | US20130136779 Method of producing nano- and microcapsules of spider silk protein |
| 05/30/2013 | US20130136775 Hydrophobic drug-delivery material, method for manufacturing thereof and methods for delivery of a drug-delivery composition |
| 05/30/2013 | US20130136774 Polymeric drug-delivery material, method for manufacturing thereof and method for delivery of a drug-delivery composition |
| 05/30/2013 | US20130136773 Expandable Placental Membrane and Methods of Making and Storing Same |
| 05/30/2013 | US20130136752 Ophthalmic Formulations |
| 05/30/2013 | US20130136702 Method of neutralizing an aerosol containing a compound of interest dissolved in a low ph solution |
| 05/30/2013 | US20130136696 Metallic nanoparticles with coated shells and applications of same |
| 05/30/2013 | US20130136688 Nanoparticles for Targeted Delivery of Active Agents to the Lung |
| 05/30/2013 | CA2856692A1 Imatinib solid dosage forms reconstituted just before use |
| 05/30/2013 | CA2856642A1 Platelet lysate gel |
| 05/30/2013 | CA2856520A1 Natural combination hormone replacement formulations and therapies |
| 05/30/2013 | CA2856501A1 A drug carrier with chelating complex micelles and the application thereof |
| 05/30/2013 | CA2856406A1 Pharmaceutical formulations |
| 05/30/2013 | CA2853764A1 Immediate release abuse deterrent tablet |
| 05/29/2013 | EP2597453A2 Load measuring device and method for mechanical load testing |
| 05/29/2013 | EP2597097A1 Substituted indoles, antiviral active component, method for producing and using same |
| 05/29/2013 | EP2597086A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 05/29/2013 | EP2596813A1 Sheet preparation for tissue adhesion |
| 05/29/2013 | EP2596802A1 Pharmaceutical composition for treatment of allergic reactions |
| 05/29/2013 | EP2596797A1 A vaginal capsule |